Lucio Vera-Cabrera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lucio Vera-Cabrera has a total of 209 co-authors. Here are the top co-authors by number of shared publications:
Jorge Ocampo-Candiani
Universidad Autónoma de Nuevo León, Laboratorio Interdisciplinario de Investigación Dermatológica, Servicio de Dermatología, Hospital Universitario “Dr José Eleuterio González
27 shared publicationsOliverio Welsh
Servicio de Dermatología, Facultad de Medicina y Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico
17 shared publications- Carmen Amelia Molina Torres
Universidad Autonóma de Nuevo León
14 shared publications - Jorge Ocampo-Candiani
Department of Dermatology, Hospital Universitario “Dr. José Eleuterio González” Universidad Autónoma de Nuevo León Monterrey México
10 shared publications - Jorge Castro-Garza
Division de Biologia Celular of Molecular, Centro de Investigacion, Biomedica sdel Noreste, IMSS, Monetary, NL, Mexico
7 shared publications - Salvador Said-Fernández
Centro de Investigación del IPN
7 shared publications
Latest Publications
- Open Access
- 15 June 2026
- Published by Frontiers Media SA in Frontiers in Tropical Diseases
- Vol. 7, 1816874
In vitro activity of omadacycline and eravacycline against Nocardia brasiliensis isolates
Actinomycetoma is a chronic, debilitating, neglected tropical disease primarily caused by Nocardia brasiliensis in Mexico and Central America. Current therapeutic standards involving high-dose trimethoprim–sulfamethoxazole are often complicated by significant toxicity and the requirement for long-term administration, highlighting an urgent need for effective oral alternatives. This study was undertaken to evaluate the potential of third-generation tetracyclines as superior therapeutic candidates. This study assessed the in vitro activity of omadacycline and eravacycline against 50 clinical isolates of Nocardia brasiliensis from human actinomycetoma cases. Susceptibility testing was done using E-test strips with omadacycline, eravacycline, and three other antimicrobials that served as comparators (trimethoprim–sulfamethoxazole, tigecycline, and minocycline). Eravacycline exhibited the highest potency (MIC 50 /MIC 90 : 0.047/0.094 μg/mL), significantly lower than omadacycline (1.0/1.5 μg/mL) and trimethoprim–sulfamethoxazole (0.19/1.0 μg/mL). These results demonstrate that eravacycline is a highly potent, promising oral therapeutic option for actinomycetoma. This work represents a major conceptual advance by identifying a highly active candidate that, due to its favorable pharmacokinetics and oral bioavailability, could transform clinical management in rural endemic regions by facilitating outpatient therapy and improving patient adherence. Further clinical validation through in vivo studies is now required to confirm these promising in vitro findings.
- 15 June 2026
- Published by Frontiers Media SA in Frontiers in Tropical Diseases
- Vol. 7, 1816874
Open AccessIn vitro activity of omadacycline and eravacycline against Nocardia brasiliensis isolates
Actinomycetoma is a chronic, debilitating, neglected tropical disease primarily caused by Nocardia brasiliensis in Mexico and Central America. Current therapeutic standards involving high-dose trimethoprim–sulfamethoxazole are often complicated by significant toxicity and the requirement for long-term administration, highlighting an urgent need for effective oral alternatives. This study was undertaken to evaluate the potential of third-generation tetracyclines as superior therapeutic candidates. This study assessed the in vitro activity of omadacycline and eravacycline against 50 clinical isolates of Nocardia brasiliensis from human actinomycetoma cases. Susceptibility testing was done using E-test strips with omadacycline, eravacycline, and three other antimicrobials that served as comparators (trimethoprim–sulfamethoxazole, tigecycline, and minocycline). Eravacycline exhibited the highest potency (MIC 50 /MIC 90 : 0.047/0.094 μg/mL), significantly lower than omadacycline (1.0/1.5 μg/mL) and trimethoprim–sulfamethoxazole (0.19/1.0 μg/mL). These results demonstrate that eravacycline is a highly potent, promising oral therapeutic option for actinomycetoma. This work represents a major conceptual advance by identifying a highly active candidate that, due to its favorable pharmacokinetics and oral bioavailability, could transform clinical management in rural endemic regions by facilitating outpatient therapy and improving patient adherence. Further clinical validation through in vivo studies is now required to confirm these promising in vitro findings.
- 23 October 2025
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 45 (2) , 303-314
Cutaneous botryomycosis: a comprehensive review
Purpose Cutaneous botryomycosis is a chronic, granulomatous infection of the skin caused by different bacteria that form granular aggregates. We aim to provide a complete, comprehensive, and updated review of cutaneous botryomycosis, including a review of cases published in the last decade. Results Patients with botryomycosis typically present multiple nodules, sinuses, abscesses, fistulae, and ulcers, which develop during weeks or months. The current gold standard for diagnosing botryomycosis involves a combination of histopathological examination and microbial culture. A definitive diagnosis is established when clinical and pathological findings align with the presence of botryomycosis, supported by the identification of non-filamentous bacteria forming granules and positive culture. The most frequent isolated etiological agents are Staphylococcus aureus followed by Pseudomonas aeruginosa. The differential diagnosis includes mycetoma, actinomycosis, and carcinomas/sarcomas. Treatment includes antibiotics and, in selected cases, surgical debridement.
- 23 October 2025
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 45 (2) , 303-314
Cutaneous botryomycosis: a comprehensive review
Purpose Cutaneous botryomycosis is a chronic, granulomatous infection of the skin caused by different bacteria that form granular aggregates. We aim to provide a complete, comprehensive, and updated review of cutaneous botryomycosis, including a review of cases published in the last decade. Results Patients with botryomycosis typically present multiple nodules, sinuses, abscesses, fistulae, and ulcers, which develop during weeks or months. The current gold standard for diagnosing botryomycosis involves a combination of histopathological examination and microbial culture. A definitive diagnosis is established when clinical and pathological findings align with the presence of botryomycosis, supported by the identification of non-filamentous bacteria forming granules and positive culture. The most frequent isolated etiological agents are Staphylococcus aureus followed by Pseudomonas aeruginosa. The differential diagnosis includes mycetoma, actinomycosis, and carcinomas/sarcomas. Treatment includes antibiotics and, in selected cases, surgical debridement.
- 24 July 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 389 (6758) , eadu7144
Pre-European contact leprosy in the Americas and its current persistence
Leprosy, caused primarily by Mycobacterium leprae , is considered a disease introduced into the Americas during European colonization. However, the recent discovery of a second pathogen causing leprosy, M. lepromatosis , mainly found in the Americas, challenges this view. Here, we show that M. lepromatosis infected humans in the Americas before European contact. By screening 389 ancient and 408 contemporary samples, we have expanded the genetic data available for the species. Phylogenetic analyses revealed distinct human-infecting clades of M. lepromatosis , with one dominating North America since colonial times. The presence of millennia-old strains in North and South America indicates that M. lepromatosis may have been widespread during the Late Holocene, demonstrating that M. lepromatosis leprosy has a long-standing history in the Americas before European arrival.
- 24 July 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 389 (6758) , eadu7144
Pre-European contact leprosy in the Americas and its current persistence
Leprosy, caused primarily by Mycobacterium leprae , is considered a disease introduced into the Americas during European colonization. However, the recent discovery of a second pathogen causing leprosy, M. lepromatosis , mainly found in the Americas, challenges this view. Here, we show that M. lepromatosis infected humans in the Americas before European contact. By screening 389 ancient and 408 contemporary samples, we have expanded the genetic data available for the species. Phylogenetic analyses revealed distinct human-infecting clades of M. lepromatosis , with one dominating North America since colonial times. The presence of millennia-old strains in North and South America indicates that M. lepromatosis may have been widespread during the Late Holocene, demonstrating that M. lepromatosis leprosy has a long-standing history in the Americas before European arrival.
- 17 April 2025
- Published by Elsevier in Microbial Pathogenesis
- Vol. 204, 107612
Immune response in BALB/c mice to an attenuated strain of Nocardia brasiliensis
- 17 April 2025
- Published by Elsevier in Microbial Pathogenesis
- Vol. 204, 107612
Immune response in BALB/c mice to an attenuated strain of Nocardia brasiliensis
- Open Access
- 11 April 2025
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 19 (4) , e0013016
Actinomadura welshii sp. nov., a New Mycetoma Agent in Mexico
Actinomadura isolates obtained from seven human mycetoma cases in Mexico were characterized using nucleotide sequence analysis of a portion of the small subunit ribosomal RNA gene. Most isolates were identified as Actinomadura madurae. However, one isolate, LIID-AQ337, showed inconclusive results. To determine its identity, genomic DNA from LIID-AQ337 was subjected to whole-genome sequencing using both short- and long-read sequencing, resulting in a genome of 8,163,638-bp spread in 22 contigs. Comparative analysis against currently available genomes of other Actinomadura species suggested that LIID-AQ337 belongs to a new Actinomadura species. We propose to name it Actinomadura welshii sp. nov in honor of Oliverio Welsh, a Mexican dermatologist dedicated to mycetoma studies in Mexico.
- 11 April 2025
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 19 (4) , e0013016
Open AccessActinomadura welshii sp. nov., a New Mycetoma Agent in Mexico
Actinomadura isolates obtained from seven human mycetoma cases in Mexico were characterized using nucleotide sequence analysis of a portion of the small subunit ribosomal RNA gene. Most isolates were identified as Actinomadura madurae. However, one isolate, LIID-AQ337, showed inconclusive results. To determine its identity, genomic DNA from LIID-AQ337 was subjected to whole-genome sequencing using both short- and long-read sequencing, resulting in a genome of 8,163,638-bp spread in 22 contigs. Comparative analysis against currently available genomes of other Actinomadura species suggested that LIID-AQ337 belongs to a new Actinomadura species. We propose to name it Actinomadura welshii sp. nov in honor of Oliverio Welsh, a Mexican dermatologist dedicated to mycetoma studies in Mexico.
- Open Access
- 8 December 2023
- Published by Instituto Nacional de Salud Publica in Salud Pública de México
- Vol. 66 (1, ene-feb) , 10-11
Isolation and characterization of nontuberculous mycobacteria in drinking water of Monterrey, Mexico
- 8 December 2023
- Published by Instituto Nacional de Salud Publica in Salud Pública de México
- Vol. 66 (1, ene-feb) , 10-11
Open AccessIsolation and characterization of nontuberculous mycobacteria in drinking water of Monterrey, Mexico
- Open Access
- 1 September 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 97 (5) , 637-640
Kerion celsi causado por Trichophyton tonsurans em adulto
- 1 September 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 97 (5) , 637-640
Open AccessKerion celsi causado por Trichophyton tonsurans em adulto
- Open Access
- 15 July 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 97 (5) , 637-640
Kerion celsi caused by Trichophyton tonsurans in an adult
- 15 July 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 97 (5) , 637-640
Open AccessKerion celsi caused by Trichophyton tonsurans in an adult
- Open Access
- 13 July 2022
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 12, 875909
Genetic Diversity of Mycobacterium tuberculosis Isolates From an Amerindian Population in Chiapas, México
This is the first report of the genetic diversity of the Mycobacterium tuberculosis complex isolates found in a Mexican-Amerindian setting. In this study, we analyzed isolates collected from the Highlands region of Chiapas, Mexico, by using spoligotyping and whole-genome sequencing analyses. Seventy-three M. tuberculosis isolates were analyzed initially by spoligotyping; no new spoligotypes were identified. Nineteen percent of the isolates were identified as SIT53 (T1) (n = 14), followed by SIT42 (14%, n = 10, LAM9) and SIT119 (11%; n = 8, X1). SIT53, SIT42, and orphan isolates (16.4%, n = 12) constituted about 50% of the isolates studied and were subjected to whole-genome sequencing (WGS) analysis. Most SIT53 (10/12) isolates belonged to the Euro-American sub-lineage 4.8. Most SIT42 isolates (4/7) as .well as most orphan isolates (5/8) belonged to the lineage 4.3.3 LAM group. By comparing the single-nucleotide polymorphism (SNP) patterns of the SIT53 isolates, we found one clone (<7 SNPs) and four clustered isolates (<15 SNPs). In isolates from the SIT42 and orphan groups, we did not find any clones or clusters. This work demonstrates the success of sub-lineage 4.8 to predominate in Mexico and confirms the dominion of sub-lineage 4.3.3 in Central and South America.
- 13 July 2022
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 12, 875909
Open AccessGenetic Diversity of Mycobacterium tuberculosis Isolates From an Amerindian Population in Chiapas, México
This is the first report of the genetic diversity of the Mycobacterium tuberculosis complex isolates found in a Mexican-Amerindian setting. In this study, we analyzed isolates collected from the Highlands region of Chiapas, Mexico, by using spoligotyping and whole-genome sequencing analyses. Seventy-three M. tuberculosis isolates were analyzed initially by spoligotyping; no new spoligotypes were identified. Nineteen percent of the isolates were identified as SIT53 (T1) (n = 14), followed by SIT42 (14%, n = 10, LAM9) and SIT119 (11%; n = 8, X1). SIT53, SIT42, and orphan isolates (16.4%, n = 12) constituted about 50% of the isolates studied and were subjected to whole-genome sequencing (WGS) analysis. Most SIT53 (10/12) isolates belonged to the Euro-American sub-lineage 4.8. Most SIT42 isolates (4/7) as .well as most orphan isolates (5/8) belonged to the lineage 4.3.3 LAM group. By comparing the single-nucleotide polymorphism (SNP) patterns of the SIT53 isolates, we found one clone (<7 SNPs) and four clustered isolates (<15 SNPs). In isolates from the SIT42 and orphan groups, we did not find any clones or clusters. This work demonstrates the success of sub-lineage 4.8 to predominate in Mexico and confirms the dominion of sub-lineage 4.3.3 in Central and South America.
- Open Access
- 1 March 2022
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 28 (3) , 747-749
Mycobacterium leprae Infection in a Wild Nine-Banded Armadillo, Nuevo León, Mexico
Nine-banded armadillos (Dasypus novemcinctus) are naturally infected with Mycobacterium leprae and are implicated in the zoonotic transmission of leprosy in the United States. In Mexico, the existence of such a reservoir remains to be characterized. We describe a wild armadillo infected by M. leprae in the state of Nuevo León, Mexico.
- 1 March 2022
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 28 (3) , 747-749
Open AccessMycobacterium leprae Infection in a Wild Nine-Banded Armadillo, Nuevo León, Mexico
Nine-banded armadillos (Dasypus novemcinctus) are naturally infected with Mycobacterium leprae and are implicated in the zoonotic transmission of leprosy in the United States. In Mexico, the existence of such a reservoir remains to be characterized. We describe a wild armadillo infected by M. leprae in the state of Nuevo León, Mexico.